HOPITAL-SAINTE-JUSTINE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 11244
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
 
 
C07K PEPTIDES 1135
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8652791 Method of classifying human subjects having adolescent idiopathic scoliosis (AIS) and method for screening for a compound useful in the treatment of AIS and related syndromes causing spinal deformitiesDec 24, 12Feb 18, 14[C12Q, G01N]
8030293 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disordersAug 04, 09Oct 04, 11[A61K, A01N]
7989175 Method of classifying human subjects having adolescent idiopathic scoliosisSep 11, 08Aug 02, 11[G01N]
7625876 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disordersAug 20, 07Dec 01, 09[A61K, A01N]
7442763 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosisJun 04, 02Oct 28, 08[A61K]
7429570 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disordersMar 21, 07Sep 30, 08[A61K]
7425546 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disordersMar 22, 07Sep 16, 08[A61K]
7105497 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disordersJun 14, 05Sep 12, 06[A61K]
6987097 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disordersNov 06, 03Jan 17, 06[A61K]
6554831 Mobile dynamic system for treating spinal disorderSep 01, 00Apr 29, 03[A61B]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0113,313 METHOD OF DIAGNOSING ADOLESCENT IDIOPATHIC SCOLIOSISAbandonedDec 30, 13Apr 24, 14[G01N]
2012/0196,878 METHODS OF OPTIMIZING DRUG THERAPEUTIC EFFICACY FOR TREATMENT OF IMMUNE-MEDIATED GASTROINTESTINAL DISORDERSAbandonedAug 30, 11Aug 02, 12[A61K, A61P]
2012/0009,600 METHOD OF DIAGNOSING ADOLESCENT IDIOPATHIC SCOLIOSISAbandonedJun 21, 11Jan 12, 12[C12Q, G01N]
2011/0256,582 METHOD OF CLASSIFYING HUMAN SUBJECTS HAVING ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS) AND METHOD FOR SCREENING FOR A COMPOUND USEFUL IN THE TREATMENT OF AIS AND RELATED SYNDROMES CAUSING SPINAL DEFORMITIESAbandonedJun 21, 11Oct 20, 11[C12Q]
7326694 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disordersExpiredMay 26, 06Feb 05, 08[A61K]
6984719 Peptide antagonists of prostaglandin F2α receptorExpiredSep 15, 99Jan 10, 06[A61K, A01N, C07K]
2005/0130,250 Method of diagnosing adolescent idiopathic scoliosis and related syndromesAbandonedAug 27, 04Jun 16, 05[C12Q]
2004/0235,749 G-protein coupled receptor antagonistsAbandonedOct 02, 03Nov 25, 04[A61K]
6812333 Identification of arsacs mutations and methods of use thereforExpiredOct 20, 00Nov 02, 04[C07H, C12N, C07K]
6680302 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disordersExpiredDec 27, 01Jan 20, 04[A61K]
2003/0017,137 VPR-DRIVEN DNA OR RNA CONSTRUCT AND THERAPEUTIC USES THEREOFAbandonedJul 22, 98Jan 23, 03[A61K, C07H, C12N]
6300139 FTCD antigenExpiredAug 13, 99Oct 09, 01[C07H, G01N]
6083719 Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesisExpiredOct 27, 97Jul 04, 00[C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.